69 related articles for article (PubMed ID: 30931090)
1. 3-Aminoazetidin-2-one derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors suitable for systemic administration.
Fiasella A; Nuzzi A; Summa M; Armirotti A; Tarozzo G; Tarzia G; Mor M; Bertozzi F; Bandiera T; Piomelli D
ChemMedChem; 2014 Jul; 9(7):1602-14. PubMed ID: 24828120
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of N-(2-oxo-3-oxetanyl)amides as N-acylethanolamine-hydrolyzing acid amidase inhibitors.
Solorzano C; Antonietti F; Duranti A; Tontini A; Rivara S; Lodola A; Vacondio F; Tarzia G; Piomelli D; Mor M
J Med Chem; 2010 Aug; 53(15):5770-81. PubMed ID: 20604568
[TBL] [Abstract][Full Text] [Related]
3. Lysosome targeting fluorescent probe for NAAA imaging and its applications in the drug development for anti-inflammatory.
Zhou L; Tian M; Zhang B; Cao X; Huo X; Yang F; Cao P; Feng L; Ma X; Tian X
Int J Biol Macromol; 2024 Apr; 263(Pt 2):130307. PubMed ID: 38382784
[TBL] [Abstract][Full Text] [Related]
4. NAAA-regulated lipid signaling in monocytes controls the induction of hyperalgesic priming in mice.
Fotio Y; Mabou Tagne A; Squire E; Lee HL; Phillips CM; Chang K; Ahmed F; Greenberg AS; Villalta SA; Scarfone VM; Spadoni G; Mor M; Piomelli D
Nat Commun; 2024 Feb; 15(1):1705. PubMed ID: 38402219
[TBL] [Abstract][Full Text] [Related]
5. NMI-SO
Babu A; Sunil K; Sajith AM; Reddy EK; Santra S; Zyryanov GV; Venkatesh T; Bhadrachari S; Nibin Joy M
Pharmaceuticals (Basel); 2024 Apr; 17(5):. PubMed ID: 38794119
[TBL] [Abstract][Full Text] [Related]
6. Recent insights about pyrrolidine core skeletons in pharmacology.
Poyraz S; Döndaş HA; Döndaş NY; Sansano JM
Front Pharmacol; 2023; 14():1239658. PubMed ID: 37745071
[TBL] [Abstract][Full Text] [Related]
7. Pyrrolidine in Drug Discovery: A Versatile Scaffold for Novel Biologically Active Compounds.
Li Petri G; Raimondi MV; Spanò V; Holl R; Barraja P; Montalbano A
Top Curr Chem (Cham); 2021 Aug; 379(5):34. PubMed ID: 34373963
[TBL] [Abstract][Full Text] [Related]
8.
Piomelli D; Scalvini L; Fotio Y; Lodola A; Spadoni G; Tarzia G; Mor M
J Med Chem; 2020 Jul; 63(14):7475-7490. PubMed ID: 32191459
[No Abstract] [Full Text] [Related]
9. Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as
Zhou P; Xiang L; Zhao D; Ren J; Qiu Y; Li Y
Medchemcomm; 2019 Feb; 10(2):252-262. PubMed ID: 30931090
[No Abstract] [Full Text] [Related]
10. Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives.
Li Y; Chen Q; Yang L; Li Y; Zhang Y; Qiu Y; Ren J; Lu C
Eur J Med Chem; 2017 Oct; 139():214-221. PubMed ID: 28802121
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors.
Malamas MS; Farah SI; Lamani M; Pelekoudas DN; Perry NT; Rajarshi G; Miyabe CY; Chandrashekhar H; West J; Pavlopoulos S; Makriyannis A
Bioorg Med Chem; 2020 Jan; 28(1):115195. PubMed ID: 31761726
[TBL] [Abstract][Full Text] [Related]
12. Progress in the development of β-lactams as N-Acylethanolamine Acid Amidase (NAAA) inhibitors: Synthesis and SAR study of new, potent N-O-substituted derivatives.
Petracca R; Ponzano S; Bertozzi SM; Sasso O; Piomelli D; Bandiera T; Bertozzi F
Eur J Med Chem; 2017 Jan; 126():561-575. PubMed ID: 27915171
[TBL] [Abstract][Full Text] [Related]
13. Inflammation-restricted anti-inflammatory activities of a N-acylethanolamine acid amidase (NAAA) inhibitor F215.
Li Y; Zhou P; Chen H; Chen Q; Kuang X; Lu C; Ren J; Qiu Y
Pharmacol Res; 2018 Jun; 132():7-14. PubMed ID: 29572189
[TBL] [Abstract][Full Text] [Related]
14. Advances in the discovery of N-acylethanolamine acid amidase inhibitors.
Bandiera T; Ponzano S; Piomelli D
Pharmacol Res; 2014 Aug; 86():11-7. PubMed ID: 24798679
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
